FR2442851A1 - Nouvelles spiro(4 h-2,3-dihydrovenzopyranne(4,5')oxazolidine)-2',4'-diones et medicament en contenant - Google Patents

Nouvelles spiro(4 h-2,3-dihydrovenzopyranne(4,5')oxazolidine)-2',4'-diones et medicament en contenant

Info

Publication number
FR2442851A1
FR2442851A1 FR7920969A FR7920969A FR2442851A1 FR 2442851 A1 FR2442851 A1 FR 2442851A1 FR 7920969 A FR7920969 A FR 7920969A FR 7920969 A FR7920969 A FR 7920969A FR 2442851 A1 FR2442851 A1 FR 2442851A1
Authority
FR
France
Prior art keywords
diones
oxazolidine
dihydrovenzopyranne
medicinal container
new spiro
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7920969A
Other languages
English (en)
French (fr)
Other versions
FR2442851B1 (US08088918-20120103-C00476.png
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Inc
Original Assignee
Pfizer Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Inc filed Critical Pfizer Inc
Publication of FR2442851A1 publication Critical patent/FR2442851A1/fr
Application granted granted Critical
Publication of FR2442851B1 publication Critical patent/FR2442851B1/fr
Granted legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D335/00Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom
    • C07D335/04Heterocyclic compounds containing six-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D335/06Benzothiopyrans; Hydrogenated benzothiopyrans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/02Drugs for disorders of the nervous system for peripheral neuropathies
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/22Anxiolytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00Drugs for disorders of the senses
    • A61P27/02Ophthalmic agents
    • A61P27/12Ophthalmic agents for cataracts
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D311/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07FACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F7/00Compounds containing elements of Groups 4 or 14 of the Periodic Table
    • C07F7/02Silicon compounds
    • C07F7/08Compounds having one or more C—Si linkages
    • C07F7/18Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
    • C07F7/1804Compounds having Si-O-C linkages

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Ophthalmology & Optometry (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Obesity (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Pyrane Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Photosensitive Polymer And Photoresist Processing (AREA)
  • Moulding By Coating Moulds (AREA)
  • Dental Preparations (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
FR7920969A 1978-08-21 1979-08-20 Nouvelles spiro(4 h-2,3-dihydrovenzopyranne(4,5')oxazolidine)-2',4'-diones et medicament en contenant Granted FR2442851A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/935,199 US4200642A (en) 1978-08-21 1978-08-21 Spiro-oxazolidindiones

Publications (2)

Publication Number Publication Date
FR2442851A1 true FR2442851A1 (fr) 1980-06-27
FR2442851B1 FR2442851B1 (US08088918-20120103-C00476.png) 1983-06-17

Family

ID=25466700

Family Applications (3)

Application Number Title Priority Date Filing Date
FR7920969A Granted FR2442851A1 (fr) 1978-08-21 1979-08-20 Nouvelles spiro(4 h-2,3-dihydrovenzopyranne(4,5')oxazolidine)-2',4'-diones et medicament en contenant
FR8002697A Granted FR2440949A1 (fr) 1978-08-21 1980-02-07 Nouveaux 4-hydroxy-4h-2,3-dihydrobenzopyranne-4-carboximidates, utiles comme intermediaires chimiques
FR8002698A Granted FR2440950A1 (fr) 1978-08-21 1980-02-07 Nouveaux 4-hydroxy-4h-2,3-dihydrobenzopyranne-4-carboxamides, utiles comme intermediaires chimiques

Family Applications After (2)

Application Number Title Priority Date Filing Date
FR8002697A Granted FR2440949A1 (fr) 1978-08-21 1980-02-07 Nouveaux 4-hydroxy-4h-2,3-dihydrobenzopyranne-4-carboximidates, utiles comme intermediaires chimiques
FR8002698A Granted FR2440950A1 (fr) 1978-08-21 1980-02-07 Nouveaux 4-hydroxy-4h-2,3-dihydrobenzopyranne-4-carboxamides, utiles comme intermediaires chimiques

Country Status (34)

Country Link
US (1) US4200642A (US08088918-20120103-C00476.png)
JP (4) JPS6011914B2 (US08088918-20120103-C00476.png)
AR (1) AR225614A1 (US08088918-20120103-C00476.png)
AT (1) AT366689B (US08088918-20120103-C00476.png)
AU (1) AU535170B2 (US08088918-20120103-C00476.png)
BE (1) BE878311A (US08088918-20120103-C00476.png)
CA (1) CA1121361A (US08088918-20120103-C00476.png)
CH (1) CH639974A5 (US08088918-20120103-C00476.png)
CS (1) CS208129B2 (US08088918-20120103-C00476.png)
DD (1) DD146602A5 (US08088918-20120103-C00476.png)
DE (2) DE2953954C2 (US08088918-20120103-C00476.png)
DK (1) DK258479A (US08088918-20120103-C00476.png)
EG (1) EG14639A (US08088918-20120103-C00476.png)
ES (1) ES483511A1 (US08088918-20120103-C00476.png)
FI (1) FI65255C (US08088918-20120103-C00476.png)
FR (3) FR2442851A1 (US08088918-20120103-C00476.png)
GB (2) GB2028318B (US08088918-20120103-C00476.png)
GR (1) GR71913B (US08088918-20120103-C00476.png)
HU (1) HU179746B (US08088918-20120103-C00476.png)
IE (1) IE48932B1 (US08088918-20120103-C00476.png)
IL (1) IL58076A (US08088918-20120103-C00476.png)
IN (1) IN152416B (US08088918-20120103-C00476.png)
IT (1) IT1123536B (US08088918-20120103-C00476.png)
LU (1) LU81613A1 (US08088918-20120103-C00476.png)
NL (1) NL7906318A (US08088918-20120103-C00476.png)
NO (1) NO792699L (US08088918-20120103-C00476.png)
NZ (1) NZ191350A (US08088918-20120103-C00476.png)
PH (1) PH18091A (US08088918-20120103-C00476.png)
PL (1) PL130686B1 (US08088918-20120103-C00476.png)
PT (1) PT70086A (US08088918-20120103-C00476.png)
SE (1) SE447116B (US08088918-20120103-C00476.png)
SU (1) SU942597A3 (US08088918-20120103-C00476.png)
YU (1) YU41488B (US08088918-20120103-C00476.png)
ZA (1) ZA794379B (US08088918-20120103-C00476.png)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4329459A (en) * 1980-05-05 1982-05-11 The Upjohn Company Tetrahydrobenzopyran derivatives
GB2080803B (en) * 1980-07-28 1984-01-18 Pfizer Hypoglycemic 5-substituted oxazolidine-2,4-diones
US4367234A (en) * 1980-07-28 1983-01-04 Pfizer Inc. Hypoglycemic 5-substituted oxazolidine-2,4-diones
ES515751A0 (es) * 1981-10-13 1983-10-16 Pfizer "un procedimiento por analogia para la preparacion de derivados de espiro-oxindol-oxazolidindiona".
US4540700A (en) * 1982-04-15 1985-09-10 Alcon Laboratories, Inc. Treatment of diabetic complications with certain spiro-imidazolidine-diones
US4464385A (en) * 1982-04-15 1984-08-07 Alcon Laboratories, Inc. Treatment of diabetic complications with hydantoins
US4436745A (en) 1982-04-15 1984-03-13 Alcon Laboratories, Inc. Method of inhibiting aldose reductase activity
US4438272A (en) 1982-04-15 1984-03-20 Alcon Laboratories, Inc. Spiro-(fluoren-9,4'-imidazolidine)-2',5'-diones
ZA832679B (en) * 1982-05-07 1983-12-28 Ici Plc Indoline derivatives
US4430337A (en) 1982-06-23 1984-02-07 Pfizer Inc. Alicyclic substituted oxazolidine-2,4-diones having hypoglycemic activity
US4556670A (en) * 1982-12-06 1985-12-03 Pfizer Inc. Spiro-3-hetero-azolones for treatment of diabetic complications
US4464380A (en) * 1983-05-25 1984-08-07 Pfizer Inc. Imidazolidinedione derivatives
US4533667A (en) * 1983-05-25 1985-08-06 Pfizer Inc. Imidazolidinedione derivatives
DK277484A (da) * 1983-06-23 1984-12-24 Hoffmann La Roche Thiazolidinderivater
JPS61200991A (ja) * 1985-03-04 1986-09-05 Sanwa Kagaku Kenkyusho:Kk スピロ―3―ヘテロアゾリジン化合物、その製法及びそれを有効成分とする糖尿病合併症の予防及び治療剤
DE3522791C1 (en) * 1985-06-26 1987-01-02 Ferroplast Gmbh Positioning wall for lagging a cavity to be filled with a hardenable material in mining or tunnelling
US4853410A (en) * 1986-01-17 1989-08-01 Pfizer Inc. Hydroxyacetic acid derivatives for the treatment of diabetic complications
US5039672A (en) * 1990-04-05 1991-08-13 Pfizer Inc. Heterocyclic compounds as aldose reductase inhibitors
US5068332A (en) * 1990-10-12 1991-11-26 American Home Products Corporation Alkylidene analogs of 1'-aminospiro[isoquinoline-4(1H),3'-pyrrolidine]-1,2',3,5'(2H)-tetrones useful as aldose reductase inhibitors
US5102886A (en) * 1990-10-12 1992-04-07 American Home Products Corporation 1'-aminospiro[isoquinoline-4(1H),3'-pyrrolidine]-1,2',3,5'(2H)-tetrones and analogs thereof useful as aldose reductase inhibitors
FR2707981B1 (fr) * 1993-07-20 1995-09-01 Adir Nouveaux dérivés de benzospiroalcène, leur procédé de préparation et les compositions pharmaceutiques qui les contiennent.
ES2265952T3 (es) 1999-06-18 2007-03-01 MERCK & CO., INC. Derivados de ariltiazolidindiona y ariloxazolidindiona.
US6380191B1 (en) 1999-06-18 2002-04-30 Merck & Co. Inc. Arylthiazolidinedione and aryloxazolidinedione derivatives
ITPI20060083A1 (it) * 2006-07-11 2008-01-12 Univ Pisa Derivati 2,2-dimetilcromanici 4-spiro-eterocicilici azotati (a 5 e 6 termini) n-sostituiti quali cardio-protettori nei confronti dell'insulto ischemico
USD775790S1 (en) * 2015-11-18 2017-01-10 Ginger Damon Motorcycle jacket
CN111246828B (zh) 2017-12-21 2022-07-01 易希提卫生与保健公司 具有通道密封件的吸收性物品和制造吸收性物品的方法
WO2019125264A1 (en) 2017-12-21 2019-06-27 Essity Hygiene And Health Aktiebolag Absorbent article comprising strong channel sealing bonds

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1204232B (de) * 1959-07-16 1965-11-04 Ncr Co Verfahren zur Herstellung von Derivaten von 3-Alkyl-3'-methyl-spiro[benzoxazolin-2, 2'-(2'H-1'-benzopyran)]
US3532744A (en) * 1967-07-28 1970-10-06 American Home Prod 1- and 2-amino substituted indane and tetralene carboxylic acids
US3821383A (en) * 1972-07-10 1974-06-28 Ayerst Mckenna & Harrison Compositions for and a method of treating diabetic complications
CA1088945A (en) * 1976-10-18 1980-11-04 Pfizer Limited Hydantoin derivatives as therapeutic agents

Also Published As

Publication number Publication date
FI792567A (fi) 1980-02-22
YU41488B (en) 1987-08-31
PL130686B1 (en) 1984-08-31
JPS55129279A (en) 1980-10-06
ES483511A1 (es) 1980-09-01
DE2933441C2 (US08088918-20120103-C00476.png) 1987-04-23
NZ191350A (en) 1984-04-27
CS208129B2 (en) 1981-08-31
FR2440949A1 (fr) 1980-06-06
IT1123536B (it) 1986-04-30
DK258479A (da) 1980-02-22
FR2442851B1 (US08088918-20120103-C00476.png) 1983-06-17
GB2033904A (en) 1980-05-29
FR2440949B1 (US08088918-20120103-C00476.png) 1981-06-12
AU5009279A (en) 1980-02-28
JPS5946517B2 (ja) 1984-11-13
GB2028318A (en) 1980-03-05
DE2933441A1 (de) 1980-02-28
AR225614A1 (es) 1982-04-15
US4200642A (en) 1980-04-29
FR2440950B1 (US08088918-20120103-C00476.png) 1981-06-12
SE7906949L (sv) 1980-02-22
JPS5528996A (en) 1980-02-29
AT366689B (de) 1982-04-26
IE791592L (en) 1980-02-21
NL7906318A (nl) 1980-02-25
PH18091A (en) 1985-03-20
LU81613A1 (fr) 1980-04-21
BE878311A (fr) 1980-02-20
JPS6011915B2 (ja) 1985-03-28
AU535170B2 (en) 1984-03-08
IN152416B (US08088918-20120103-C00476.png) 1984-01-07
CA1121361A (en) 1982-04-06
PT70086A (en) 1979-09-01
DE2953954A1 (US08088918-20120103-C00476.png) 1982-09-02
EG14639A (en) 1985-03-31
IL58076A (en) 1982-07-30
GR71913B (US08088918-20120103-C00476.png) 1983-08-16
SE447116B (sv) 1986-10-27
NO792699L (no) 1980-02-22
GB2028318B (en) 1982-08-04
FI65255C (fi) 1984-04-10
HU179746B (en) 1982-12-28
DD146602A5 (de) 1981-02-18
SU942597A3 (ru) 1982-07-07
FR2440950A1 (fr) 1980-06-06
FI65255B (fi) 1983-12-30
CH639974A5 (fr) 1983-12-15
PL217881A1 (US08088918-20120103-C00476.png) 1981-01-02
JPS6011914B2 (ja) 1985-03-28
JPS5943954B2 (ja) 1984-10-25
YU199979A (en) 1983-06-30
ZA794379B (en) 1980-08-27
IT7925182A0 (it) 1979-08-20
DE2953954C2 (US08088918-20120103-C00476.png) 1987-12-03
JPS55129280A (en) 1980-10-06
JPS55129288A (en) 1980-10-06
IL58076A0 (en) 1979-12-30
ATA560579A (de) 1981-09-15
IE48932B1 (en) 1985-06-26
GB2033904B (en) 1982-08-04

Similar Documents

Publication Publication Date Title
FR2442851A1 (fr) Nouvelles spiro(4 h-2,3-dihydrovenzopyranne(4,5')oxazolidine)-2',4'-diones et medicament en contenant
FR2372810A1 (fr) Nouvelles aminoalcoylimidazolidinones, procedes pour leur preparation et leur utilisation en tant que medicaments
FR2430410A1 (fr) Phenethanolamines et compositions pharmaceutiques en contenant
FR2400512A1 (fr) Nouveaux nitro-imidazoles, leur preparation et leur application en tant que medicaments
FR2382441A1 (fr) Nouveaux n-(aminoalkyl substitue)-2-oxo-1-pyrrolidine-acetamides utiles en tant que medicaments et procedes pour leur preparation
FR2430403A1 (fr) Nouvelles 15-deoxy-16-hydroxy-prostaglandines, leur procede de production et medicament les contenant
FR2444031A1 (fr) Nouveaux derives d'imidazole, leur procede de production et composition pharmaceutique les contenant
FR2383922A1 (fr) Nouvelles 4-acylamino-phenyl-ethanolamines, procede pour leur preparation et leur utilisation en tant que medicaments
FR2402640A1 (fr) Nouveaux phenols a substituant hydroxyalkyle ou oxoalkyle et composition pharmaceutique les contenant
FR2394534A1 (fr) Nouveaux 1-aryloxy-2-hydroxy-3-alcoyleneaminopropanes, procedes pour leur preparation et medicaments les renfermant
FR2391215A1 (fr) Nouvelles imidazoazines et imidazodiazines, leur preparation et leur application en tant que medicaments
FR2387229A1 (fr) Dipyrido (4,3-b) (3,4-f) indoles, procede d'obtention, application therapeutique et compositions pharmaceutiques les contenant
FR2432519A1 (fr) Nouveaux derives de purine et medicament les contenant
FR2363556A1 (fr) Nouvelles phenylethylamines, leur preparation et leur utilisation en tant que medicaments
FR2388793A1 (fr) Azetidinyl-acetonitriles et -acetamides, compositions antiarythmiques contenant ces composes et utilisation de ces compositions
FR2388795A1 (fr) Nouveaux n-(1-(3-benzoylpropyl)-4-piperidyl)-sulfamides, procedes pour leur preparation et medicaments les renfermant
FR2444674A1 (fr) Derives de n-alcynyl-n'-(omega-((thiazolyle eventuellement substitue)-methylthio)-alkyle) de n''-cyanoguanidine et d'ethylene 1,1-diamino-2-substitue, leur procede de production et medicament les contenant
FR2398067A1 (fr) Nouvelles 4-pyrones substituees en positions 2, 3 et 6 et medicament les contenant
FR2374039A1 (fr) Compositions contenant un derive de l'acide salicylique et applications a titre de medicament
FR2393577A1 (fr) Medicament a base d'acide b-(p-halogenophenyl)-g-aminobutyrique destine au traitement de la nevrose d'angoisse
FR2426039A1 (fr) Derives de di-o-n-alkylglycerols et medicament immuno-stimulant les contenant
FR2378026A1 (fr) Medicaments contenant des derives de sulfure d'hydroxymethyl-2 amino-2' diphenyle
FR2446819A1 (fr) Derives 6-alkyles d'acide 1,2-dihydro-2-oxonicotinique et composition pharmaceutique les contenant
FR2453152A1 (fr) Nouveaux derives de prostaglandine et medicament les contenant
FR2412533A1 (fr) Polyfluorohydroxyisopropyl carbostyriles bicycliques et tricycliques antihypertensifs, leur preparation et compositions pharmaceutiques les contenant

Legal Events

Date Code Title Description
ST Notification of lapse